Natera Tops Revenue Estimates at $794.0 Million; Loss Misses Forecast
Natera raised its 2026 annual revenue guidance by $140 million at the midpoint, to $3.005 billion to $3.035 billion.
Natera NTRA
Natera, Inc. · Nasdaq · Services-Medical Laboratories
$363.76-6.97%close on Nov. 5, 2026 · volume 3.2M · Yahoo Finance
Price, last 53 sessions
Our coverage
Insider buying and selling
| Date | Insider | Trade | Shares | Avg. price | Value |
|---|---|---|---|---|---|
| Nov. 3, 2026 | Michael Burkes Brophy CHIEF FINANCIAL OFFICER | Sold 10b5-1 plan | 470 | $391.49 | $184,000 |
| Nov. 2, 2026 | Jonathan Sheena director | Sold 10b5-1 plan | 112 | $399.97 $388.20-$400.29 | $44,797 |
| Nov. 2, 2026 | Matthew Rabinowitz EXECUTIVE CHAIRMAN, director | Sold 10b5-1 plan | 748 | $400.02 $388.20-$400.29 | $299,214 |
| Nov. 2, 2026 | Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER | Sold 10b5-1 plan | 341 | $400.05 $388.20-$400.29 | $136,416 |
| Nov. 2, 2026 | Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS | Sold 10b5-1 plan | 3,419 | $409.77 $388.20-$416.45 | $1.40 million |
| Nov. 2, 2026 | John Fesko PRESIDENT, CHIEF BUS. OFFICER | Sold 10b5-1 plan | 302 | $400.01 $388.20-$400.29 | $120,804 |
| Nov. 2, 2026 | Steven Leonard Chapman CEO AND PRESIDENT, director | Sold 10b5-1 plan | 3,801 | $411.80 $387.90-$415.64 | $1.57 million |
| Nov. 2, 2026 | Michael Burkes Brophy CHIEF FINANCIAL OFFICER | Sold 10b5-1 plan | 325 | $399.99 $388.03-$400.29 | $129,998 |
| Oct. 30, 2026 | Michael Burkes Brophy CHIEF FINANCIAL OFFICER | Sold 10b5-1 plan | 1,906 | $425.55 | $811,098 |
| Oct. 28, 2026 | Michael Burkes Brophy CHIEF FINANCIAL OFFICER | Sold 10b5-1 plan | 1,178 | $426.46 $425.32-$426.87 | $502,372 |
| Oct. 28, 2026 | Jonathan Sheena director | Sold 10b5-1 plan | 187 | $426.34 | $79,726 |
| Oct. 28, 2026 | Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER | Sold 10b5-1 plan | 968 | $426.34 | $412,698 |
Latest 12 of 64. Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.
Recent SEC filings
All 52 →Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedNatera Q3 2026 revenue of $794.0 million beats $707.5 million consensus and lifts FY2026 revenue guidance to $3.005-$3.035 billion, but GAAP EPS of -$0.42 misses -$0.28 consensus